Transgene Biotek Ltd Share Price
(526139)
₹4.23▲1.68%
as on 04:01PM, 03 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -8.97 % |
3 Month Return | -36.29 % |
1 Year Return | -61.94 % |
Market Stats | |
Previous Close | ₹4.16 |
Open | ₹4.34 |
Volume | 12.19K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹31.52Cr |
P/E Ratio
-138.67
PEG Ratio
-630.3
Market Cap
₹31.52 Cr
P/B Ratio
-8.95
EPS
-0.09
Dividend Yield
0Sector
Healthcare
ROE
0Key events for Transgene Biotek Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 0.1 Cr → 0.12 Cr (in ₹), with an average increase of 16.7% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 21.68% of holdings in Dec 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 70.04% of holdings in Dec 2024 quarter
Against Peers
In the last 1 year, Vimta Labs Ltd has given 65.8% return, outperforming this stock by 127.7%
Against Peers
In the last 3 years, Vimta Labs Ltd has given 163.2% return, outperforming this stock by 134.0%
Profit Down
Netprofit is down for the last 3 quarters, 0.2 Cr → -0.09 Cr (in ₹), with an average decrease of 81.8% per quarter
Price Dip
In the last 6 months, Transgene Biotek stock has moved down by -51.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 21.68% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 70.04% | 0.00 | |
Others | 8.28% | 0.00 |
Transgene Biotek Ltd in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-138.67x)
February 28, 2025
Industry (92.17x)
February 28, 2025
Highest (13.23x)
October 8, 2018
Bearish
Neutral
Bullish
Transgene Biotek Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹31.52 Cr | 5.52% | 1.11 | -₹1 Cr | NA | |
NA | ₹14.61 Cr | 25.07% | 0.60 | ₹4 Cr | ₹13 Cr | |
NA | ₹104.92 Cr | -8.81% | 0.56 | NA | NA | |
NA | ₹25.40 Cr | 48% | 1.01 | NA | NA | |
NA | ₹1,067.65 Cr | 74.25% | 0.68 | NA | NA |
Organisation | Transgene Biotek Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Transgene Biotek Ltd share price today stands at ₹4.23, Open: ₹4.34, Previous Close: ₹4.16, High: ₹4.36, Low: ₹4.01, 52 Week High: ₹11.34, 52 Week Low: ₹3.87.
Transgene Biotek Ltd is not listed on NSE
Transgene Biotek Ltd is listed on BSE
Today's traded volume of Transgene Biotek Ltd(526139) is 12.19K.
Today's market capitalisation of Transgene Biotek Ltd(526139) is ₹31.52Cr.
Transgene Biotek Ltd (526139) share price is ₹4.23. It is down -62.70% from its 52 Week High price of ₹11.34
Transgene Biotek Ltd (526139) share price is ₹4.23. It is up 9.30% from its 52 Week Low price of ₹3.87
PE Ratio of Transgene Biotek Ltd is -138.67
PE ratio = Transgene Biotek Ltd Market price per share / Transgene Biotek Ltd Earnings per share